Assisted Reproductive Technology Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Assisted Reproductive Technology refers to clinical interventions in which gametes or embryos are manipulated outside the body to achieve conception, with IVF being the most widely performed procedure. The global market was worth about USD 27.25 billion in 2025 and is forecast to grow at a CAGR near 7.0% through the end of the decade, more than doubling in value over the forecast period. Demand is broadening beyond traditional patient groups to include single parents, same-sex couples, and individuals seeking fertility preservation.

• •2025 market value: approximately USD 27.25 billion.
• •Projected CAGR: roughly 7.0% from 2025 through the early 2030s.
• •IVF, ICSI, and embryo cryopreservation are the core procedure categories.

Rising infertility rates linked to lifestyle factors, endocrine disorders, and environmental exposures are increasing the addressable patient population. Sociocultural shifts such as delayed childbearing and growing acceptance of non-traditional family structures continue to expand the consumer base for fertility services. At the same time, improvements in laboratory techniques, automation, and the wider availability of fertility coverage in several markets are making treatments more effective and accessible.

• •Increasing prevalence of infertility and age-related fertility decline.
• •Greater societal acceptance of ART and demand from single and LGBTQ+ prospective parents.
• •Technology improvements in embryo culture, genetic screening, and vitrification.

The market is typically segmented by procedure (fresh donor, fresh non-donor, frozen donor, and frozen non-donor cycles), by technique such as IVF, ICSI, and intrauterine insemination, and by end user including fertility clinics and hospitals. Frozen embryo transfer cycles have become a particularly fast-growing segment as vitrification outcomes improve. North America and Europe currently represent the largest revenue contributors due to high procedure volumes and reimbursement in selected countries, while the Asia-Pacific region is exhibiting the fastest growth as clinics expand across China, India, and Southeast Asia.

• •Frozen and donor cycles are gaining share versus fresh non-donor cycles.
• •North America and Europe lead in current revenue; Asia-Pacific is the fastest-growing region.
• •Fertility clinics are the dominant end-user channel, with hospital-based ART centers also expanding.

What are the recent trends and outlook?

The most prominent trend shaping the next decade is the application of artificial intelligence and time-lapse imaging to embryo assessment, which has the potential to improve implantation rates per cycle. Fertility preservation, particularly oocyte and embryo cryopreservation for medical and elective reasons, is expanding rapidly as awareness grows among younger women. Overall, the market is expected to continue growing at roughly 7% annually, supported by broader reimbursement policies, increasing clinic density in emerging economies, and ongoing laboratory innovation.

• •AI-based embryo selection and non-invasive genetic testing are key technological trends.
• •Elective and medical fertility preservation are expanding patient pools, especially among younger women.
• •Long-term outlook remains positive with consistent mid-to-high single-digit growth through 2030 and beyond.